Rational design of novel antiandrogens for neutralizing androgen receptor function in hormone refractory prostate cancer.
Rational design of novel antiandrogens for neutralizing androgen receptor function in hormone refractory prostate cancer. Prostate. 2008 Oct 01; 68(14):1570-81.